Home testing for COVID-19: Benefits and limitations.


Journal

Cleveland Clinic journal of medicine
ISSN: 1939-2869
Titre abrégé: Cleve Clin J Med
Pays: United States
ID NLM: 8703441

Informations de publication

Date de publication:
01 Mar 2021
Historique:
pubmed: 14 2 2021
medline: 14 2 2021
entrez: 13 2 2021
Statut: aheadofprint

Résumé

The home test kits for detecting SARS-CoV-2 infection with Food and Drug Administration emergency use authorization primarily use either isothermal nucleic acid amplification or antigen detection, and each test has advantages and limitations in terms of sensitivity and specificity, cost, results reporting, and results turnaround time. In clinical studies, these tests provide accurate positive results in symptomatic individuals, although negative results are less accurate. There are also accuracy concerns for positive results in asymptomatic individuals. These factors have implications for their clinical interpretation and use.

Identifiants

pubmed: 33579779
pii: ccjm.88a.ccc071
doi: 10.3949/ccjm.88a.ccc071
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 The Cleveland Clinic Foundation. All Rights Reserved.

Auteurs

Gary W Procop (GW)

Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH procopg@ccf.org.

Kamran Kadkhoda (K)

Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.

Daniel D Rhoads (DD)

Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH.

Steven G Gordon (SG)

Department of Infectious Diseases, Respiratory Institute, Cleveland Clinic, Cleveland, OH.

Anita J Reddy (AJ)

Department of Critical Care and Medical Operations, Respiratory Institute, Cleveland Clinic, Cleveland, OH.

Classifications MeSH